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Abstract
Introduction Total joint replacement is considered a surrogate
measure for symptomatic end-stage osteoarthritis. It is unknown
whether the adipose mass and the distribution of adipose mass
are associated with the risk of primary knee and hip replacement
for osteoarthritis. The aim of the present investigation was to
examine this in a cohort study.
Methods A total of 39,023 healthy volunteers from Melbourne,
Australia were recruited for a prospective cohort study during
1990 to 1994. Their body mass index, waist circumference, and
waist-to-hip ratio were obtained from direct anthropometric
measurements. The fat mass and percentage fat were estimated
from bioelectrical impedance analysis. Primary knee and hip
replacements for osteoarthritis between 1 January 2001 and 31
December 2005 were determined by data linkage to the
Australian Orthopaedic Association National Joint Replacement
Registry. Cox proportional hazards regression models were
used to estimate the hazard ratios (HRs) for primary joint
replacement associated with each adiposity measure.
Results Comparing the fourth quartile with the first, there was a
threefold to fourfold increased risk of primary joint replacement
associated with body weight (HR = 3.44, 95% confidence
interval (CI) = 2.83 to 4.18), body mass index (HR = 3.44, 95%
CI = 2.80 to 4.22), fat mass (HR = 3.51, 95% CI = 2.87 to
4.30), and percentage fat (HR = 2.99, 95% CI = 2.46 to 3.63).
The waist circumference (HR = 2.77, 95% CI = 2.26 to 3.39)
and waist-to-hip ratio (HR = 1.46, 95% CI = 1.21 to 1.76) were
less strongly associated with the risk. Except for the waist-to-hip
ratio, which was not significantly associated with hip
replacement risk, all adiposity measures were associated with
the risk of both knee and hip joint replacement, and were
significantly stronger risk factors for knee.
Conclusions Risk of primary knee and hip joint replacement for
osteoarthritis relates to both adipose mass and central
adiposity. This relationship suggests both biomechanical and
metabolic mechanisms associated with adiposity contribute to
the risk of joint replacement, with stronger evidence at the knee
rather than the hip.
Introduction
Total joint replacement is a very effective treatment for end-
stage, symptomatic knee and hip osteoarthritis (OA), and has
been considered a surrogate measure for severe OA. The rate
of joint replacement is steadily increasing in most developed
countries [1,2]. Major risk factors for OA are age and obesity
AOA: Australian Orthopaedic Association; BMI: body mass index; CI: confidence interval; FM: fat mass; HR: hazard ratio; IL: interleukin; MCCS: Mel-
bourne Collaborative Cohort Study; NJRR: National Joint Replacement Registry; OA: osteoarthritis; TNF: tumour necrosis factor alpha; WHR: waist-
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[3]. In developed countries, the populations are steadily aging
and obesity rates are increasing. Chronic diseases related to
aging and obesity, such as OA, will therefore probably
become more prevalent and will in turn increase the demand
for definitive therapies, such as joint replacement surgery.
Obesity has been recognized as the most important modifiable
risk factor for OA. Although there is strong evidence to sug-
gest that obesity is associated with the risk of knee OA and
that weight loss reduces the risk of developing knee OA [4-6],
the evidence for the relationship between obesity and risk of
hip OA has been less consistent [7-12]. The body mass index
(BMI) is the most commonly used measure of obesity, and
there is accumulating evidence demonstrating a positive asso-
ciation between BMI and the risk of both knee [13,14] and hip
[13-17] replacement. The BMI does not account for the pat-
tern of fat distribution or body composition, however, and can-
not discriminate adipose from nonadipose body mass [18].
Moreover, although the waist circumference and the waist-to-
hip ratio (WHR) estimate central adiposity, and have been
shown to be better predictors of several chronic diseases
such as diabetes and cardiovascular diseases than the BMI
[19], the role of central adiposity in the risk of joint replace-
ment has not been fully elucidated.
A recent population-based prospective cohort study demon-
strated increased incidences of knee and hip joint replace-
ment due to OA in relation to different body mass measures,
including BMI, waist circumference, WHR, weight, and per-
centage of body fat. The BMI was associated with much
higher relative risk than were the WHR or percentage fat, sug-
gesting a major link between overweight and biomechanics in
increasing knee and hip OA risk, but did not exclude a contrib-
uting role of metabolic factors associated with adipose tissue
[20]. Whether the adipose mass and the distribution of adi-
pose mass are associated with the risk of knee and hip joint
replacement secondary to severe OA, however, has not been
fully elucidated.
In the present study we examined the relationship between dif-
ferent adiposity measures and the risk of subsequent primary
knee and hip joint replacement for OA in a prospective cohort
study over 10 years.
Materials and methods
The cohort
The Melbourne Collaborative Cohort Study (MCCS) is a pro-
spective cohort study of 41,528 people (17,049 men) aged
between 27 and 75 years at baseline, 99.3% of whom were
aged 40 to 69 years [21]. Participants were recruited between
1990 and 1994 via Electoral Rolls (registration to vote is com-
pulsory for Australian adults), advertisements, and community
announcements in the local media (for example, television,
radio, newspapers). Southern European migrants to Australia
(including 5,425 from Italy and 4,535 from Greece) were
deliberately oversampled to extend the range of lifestyle expo-
sures and to increase genetic variation. The study protocol
was approved by The Cancer Council Victoria's Human
Research Ethics Committee.
Follow-up was conducted by record linkage to Electoral Rolls,
electronic telephone books and the Victorian Cancer Registry
and death records. From 2003 onwards, 28,046 study partic-
ipants (68% of the original MCCS participants) took part in the
second follow-up.
Study participants
Of the 41,528 participants recruited, 2,505 (6.0%) were
excluded from analysis because they: died or left Australia
prior to 1 January 2001; had undergone a sex change since
baseline; reported at the MCCS second follow-up a primary
joint replacement prior to 1 January 2001; left Australia before
the date of having a primary joint replacement; or the first
recorded procedure was a revision joint replacement as
recorded in the Australian Orthopaedic Association (AOA)
National Joint Replacement Registry (NJRR) – thus leaving
39,023 participants available for analysis.
Anthropometric measurements
Height, weight, and waist and hip circumferences were meas-
ured once at baseline attendance for each participant accord-
ing to written protocols based on standard procedures [22].
Weight was measured to the nearest 100 g using digital elec-
tronic scales. Height and waist and hip circumferences were
measured to the nearest 1 mm using a stadiometer and a
metal anthropometric tape, respectively. BMI was calculated
as the weight in kilograms divided by the square of height in
meters. The WHR was computed as the waist circumference
divided by the hip circumference.
Bioelectrical impedance analysis was performed with a single
frequency (50 kHz) electric current produced by a BIA-101A
RJL system analyser (RJL systems, Detroit, MI, USA). Resist-
ance and reactance were measured with subjects in a supine
position. The nonadipose mass, hereafter termed fat-free
mass, was estimated as 9.1536 + (0.4273 × height2/resist-
ance) + (0.1926 × weight) + (0.0667 × reactance) for males,
and as 7.7435 + (0.4542 × height2/resistance) + (0.119 ×
weight) + (0.0455 × reactance) for females [23]. The adipose
mass, hereafter termed fat mass (FM = weight - fat-free mass),
and the percentage fat (FM divided by weight) were subse-
quently calculated.
Questionnaire measures
At baseline interview, questions were asked on date of birth,
country of birth, smoking, alcohol consumption, current physi-
cal activity during leisure time, and highest level of education.
At the second follow-up, the participants were asked ques-
tions enquiring about their first joint replacement surgery:
Have you ever had a hip replacement? When did you haveAvailable online http://arthritis-research.com/content/11/2/R31
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your first hip replacement? Have you ever had a knee replace-
ment? When did you have your first knee replacement?
Identification of incident primary knee and hip joint 
replacement
All participants gave written consent allowing access to their
medical records. Cases were identified from the AOA NJRR.
The implementation of the AOA NJRR commenced in 1999
and was introduced in a staged state-by-state approach that
was completed nationally by mid 2002. Victorian data collec-
tion commenced in 2001. The Registry monitors the perform-
ance and outcome of both hip and knee replacement surgery
in Australia. It contains detailed information on the prostheses
and surgical technique used and on the clinical situation that
was used in for both primary and revision joint replacement
[24]. By using detailed matching technology it is able to deter-
mine the success or otherwise of the joint replacement sur-
gery. Although data collection for the NJRR is voluntary, the
Registry receives cooperation from all hospitals undertaking
joint replacement surgery [24].
The AOA NJRR validates its data using both internal systems
and external data sources. The most important external data
source is state health department data. Validation of registry
data against health department recorded data involves a
sequential multilevel matching process. Following the valida-
tion process and the retrieval of unreported records, the Reg-
istry collects the most complete set of data relating to hip and
knee replacement in Australia [2].
Identifying information of MCCS participants – including first
name, last name, date of birth, and gender – was provided to
the staff at the AOA NJRR in order to identify those MCCS
participants who had undergone a primary or revision joint
replacement between 1 January 2001 which is when the Reg-
istry commenced Victorian data collection, and 31 December
2005. The matching was performed on these data provided
using US Bureau of the Census Record Linkage software.
Exact matches were identified and probabilistic matches were
reviewed. The staff from the AOA NJRR forwarded this infor-
mation to the MCCS and it was then added to the MCCS
database.
The study was approved by The Cancer Council Victoria's
Human Research Ethics Committee and the Standing Com-
mittee on Ethics in Research Involving Humans of Monash Uni-
versity.
Statistical analysis
Cox proportional hazards regression models were used to
estimate the hazard ratios (HRs) for first recorded primary joint
replacement associated with each adiposity measure after
adjustment for confounding variables. Follow-up for primary
joint replacement (that is, calculation of person-time) began on
1 January 2001, and ended at date of first primary joint
replacement for OA or date of censoring. Subjects were cen-
sored at either the date of first primary joint replacement per-
formed for indications other than OA, the date of death, the
date left Australia, or 31 December 2005 (the date that ascer-
tainment of joint replacement by NJRR was complete), which-
ever came first.
Initially, all adiposity measures were categorized into approxi-
mate quartiles according to their sex-specific baseline distribu-
tion in the study population, and the association of each
measure with risk of joint replacement was analysed sepa-
rately, with the lowest quartile used as the referent category.
The BMI was also categorized according to the widely used
World Health Organization categories as follows:  24.9 kg/
m2, 25.0 to 29.9 kg/m2, and  30.0 kg/m2. The waist circum-
ference was further categorized as follows: for men,  93.9
cm, 94.0 to 101.9 cm, and  102.0 cm; and for women,  79.9
cm, 80.0 to 87.9 cm, and  88.0 cm [25]. For both BMI and
waist circumference, the first predefined sex-specific category
was the referent group. In addition, adiposity measures were
fitted as continuous covariates to estimate linear trends on the
log HR stratifying by gender. To estimate HRs separately for
knee and hip replacement risk and to test for heterogeneity,
Cox models based on competing risks were fitted using a data
duplication method [26].
The following variables were considered as potential con-
founders: age, gender, country of birth (Australia, United King-
dom, Italy, Greece), and highest level of education (primary
school, some high or technical school, completed high or
technical school, and completed tertiary degree or diploma),
since they have been shown to be related to the risk of joint
replacement [27-29]. Other potential confounding variables
(alcohol consumption (g/day), smoking (never, past, current),
and physical activity at leisure (none, low, moderate, high))
were included in all of the definitive analyses if they changed
the HRs of any of the adiposity measures by at least 5%. For
each adiposity measure, all potential confounders were
included in the model. To test whether associations between
adiposity measures and joint replacement risk were modified
by gender or BMI, interactions between these latter two varia-
bles and the adiposity measures were fitted, and tested using
the likelihood ratio test.
Tests based on Schoenfeld residuals and graphical methods
using Kaplan–Meier curves showed no evidence that propor-
tional hazard assumptions were violated for any of the adipos-
ity measures. P  < 0.05 (two-sided) was considered
statistically significant. All statistical analyses were performed
using Stata (Intercooled Stata 9.2 for Windows; StataCorp
LP, College Station, TX, USA).Arthritis Research & Therapy    Vol 11 No 2    Wang et al.
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Results
A total of 1,009 primary joint replacements (541 knee replace-
ments and 468 hip replacements) performed for OA were
identified between 1 January 2001 and 31 December 2005.
Descriptive statistics for selected characteristics of the study
participants are presented in Table 1. The means of age and
of all anthropometric measurements except for height were
greater in those with a primary joint replacement compared
with those with no joint replacement. Participants with a joint
replacement were less likely to be born in Italy or Greece when
compared with those with no joint replacement.
Relationships between individual adiposity measures and the
risk of primary joint replacement for OA, adjusted for age, gen-
der, country of birth, and highest level of education, are pre-
sented in Table 2. Weight, BMI, waist circumference, WHR,
FM, and percentage fat were all associated with an increased
risk of primary joint replacement. When participants in the
highest quartile of the adiposity measures were compared
with those in the lowest quartile, the HRs were as follows:
weight, 3.44 (95% confidence interval (CI) = 2.83 to 4.18);
BMI, 3.44 (95% CI = 2.80 to 4.22); waist circumference, 2.77
(95% CI = 2.26 to 3.39); WHR, 1.46 (95% CI = 1.21 to
1.76); FM, 3.51 (95% CI = 2.87 to 4.30); and percentage fat,
2.99 (95% CI = 2.46 to 3.63). When using the predefined
groupings of BMI and waist circumference and comparing the
second and third categories with the first category, the HRs
were 1.91 (95% CI = 1.62 to 2.24) and 3.08 (95% CI = 2.58
to 3.68) for BMI, and were 1.53 (95% CI = 1.31 to 1.79) and
2.17 (95% CI = 1.86 to 2.52) for waist circumference. Using
the continuous form of the adiposity measures revealed similar
inferences about risk of primary joint replacement as the cate-
gorical measures.
No evidence was found for a departure from a linear associa-
tion between adiposity measures and joint replacement risk
within our sex-specific observed range of adiposity measures
(see Table 2 for sex-specific quartile cutoff points). There was
no threshold effect within the sex-specific observed range of
adiposity measures.
The specificities at each quartile cutoff point were similar for
all of the adiposity measures. The sensitivities at each quartile
cutoff point, however, were lower for WHR than for the other
adiposity measures (data not shown).
The associations between adipose mass (FM and percentage
fat) and central adiposity (waist circumference and WHR)
measures and joint replacement risk were not modified by
BMI. Gender did not modify the associations between adipos-
ity measures and the risk of joint replacement, and similar
results were observed when men and women were examined
separately (Table 3).
When primary knee and hip replacement were examined sep-
arately, all of the individual adiposity anthropometric measures
were associated with an increased risk of both primary knee
and hip replacement – except that WHR was not significantly
associated with the risk of primary hip replacement (Table 4).
Moreover, all of the adiposity measures were stronger risk fac-
tors for knee rather than hip replacement. For example, for
every 5 unit increase in BMI, the HRs were 1.88 (95% CI =
1.76 to 2.00) for knee replacement and 1.26 (95% CI = 1.15
to 1.38) for hip replacement (P < 0.001 for heterogeneity of
HRs) (Table 4).
Discussion
We have demonstrated a threefold to fourfold increased risk
of primary hip and knee joint replacement for OA, when com-
paring the fourth quartile with the first quartile, for weight, BMI,
FM, and percentage fat. The waist circumference and WHR
were less strongly associated with the risk. When knee and
hip replacements were examined separately, all adiposity
measures persisted as risk factors for joint replacement at
either anatomical site – with the exception of WHR, which was
not significantly associated with hip replacement risk. Moreo-
ver, when comparing the strength of the associated risks
between the adiposity measures and knee and hip joint
replacement, all adiposity measures were stronger risk factors
for knee replacement rather than hip joint replacement.
There are few previous studies examining the relationship
between directly measured adipose mass or the distribution of
adipose mass and the risk of joint replacement. Most studies
have employed BMI as a measure of obesity, and have shown
a consistently positive association between BMI and the risk
of both knee replacements [13,14] and hip replacements [13-
17] for OA – as has the present study. In addition to examining
the association with BMI, it would be necessary to examine
whether the pattern of fat distribution or body composition
affects this risk [18], in order to explore the mechanism that
may explain the association between obesity and the
increased risk of joint replacement due to severe OA. In a
cohort of the Swedish general population (the Malmo Diet and
Cancer study), Lohmander and colleagues found that all body
mass measures were significant risk factors for knee and hip
OA leading to joint replacement [20]. Consistent with this
study, we also showed that measures of adipose mass (FM
and percentage fat) were associated with an increased risk of
primary knee and hip joint replacement 10 to 15 years after
their measurement. Whilst both measures of central adiposity
(waist circumference and WHR) were associated with an
increased risk of primary knee replacement, only waist circum-
ference but not WHR was significantly associated with the risk
of primary hip replacement. Moreover, for all measures of
obesity, stronger evidence was observed for the knee than for
the hip.Available online http://arthritis-research.com/content/11/2/R31
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The Malmo Diet and Cancer study [20] and our study are the
only two prospective studies of which we have knowledge that
have investigated the association of different adiposity meas-
ures (including direct measurement of percentage fat using
bioelectrical impedance) with joint replacement. The findings
of the Malmo Diet and Cancer study (n = 27,960) have been
confirmed in our larger study (n = 39,023). Our study also
included about 24% of participants who were Southern Euro-
pean migrants, whereas the Malmo Diet and Cancer study
excluded participants with a lack of Swedish language skills,
thus resulting in a more homogeneous population. This signif-
icantly strengthens the findings since similar results have been
found in different populations, suggesting that the association
is more likely to be causal since it is unlikely that both studies
were subject to the same type of errors (chance, bias or con-
founding).
The mechanism for the associations between adiposity meas-
ures and the risk of primary knee and hip joint replacement is
unclear, but may be due to both biomechanical and metabolic
factors. The adipose mass, by virtue of its added body mass,
contributes to an increased joint loading, which may increase
the risk of OA progression and subsequent joint replacement
performed for severe end-stage OA. This biomechanical
hypothesis may be most evident at the knee – given the ana-
tomical disadvantage that the knee joint lacks a stable bony
configuration compared with the hip, whereby load is dispro-
portionately distributed to the medial tibiofemoral compart-
ment during dynamic tasks – and it has been shown that much
of the effect of BMI on the severity of medial tibiofemoral OA
was explained by varus malalignment [30]. The association
between fat distribution and the risk of knee and hip OA has
been investigated in different study populations with inconsist-
ent results. While some studies showed positive associations
[31], other studies showed no association [5,9,32,33].
Nevertheless, metabolic factors are also likely to be important
since we have shown that waist circumference and WHR, the
surrogate measures of central adiposity and known risk factors
for the metabolic syndrome [34], were more strongly associ-
Table 1
Characteristics of the study population
Primary knee replacement (n = 
541)
Primary hip replacement (n = 468) No primary joint replacement (n = 
38,014)
Age of entering the MCCS (years) 60.3 ± 6.8 59.7 ± 7.1 54.8 ± 8.6
Age of entering the JR cohort 
(years)
68.1 ± 6.9 67.3 ± 7.2 62.6 ± 8.8
Age on JR (years) 70.7 ± 6.9 70.1 ± 7.2
Women, number (%) 344 (63.6) 283 (60.5) 22,699 (59.7)
Height (cm) 164.7 ± 9.9 165.7 ± 8.8 165.0 ± 9.3
Weight (kg) 80.7 ± 14.9 75.5 ± 13.2 73.1 ± 13.6
Body mass index (kg/m2) 29.8 ± 5.1 27.5 ± 4.3 26.8 ± 4.4
Waist circumference (cm) 91.7 ± 12.8 86.3 ± 12.7 85.1 ± 12.8
Waist-to-hip ratio 0.85 ± 0.09 0.84 ± 0.10 0.84 ± 0.09
Fat mass (kg) 32.3 ± 10.4 27.8 ± 9.1 26.0 ± 9.1
Percentage fat (%) 39.7 ± 8.6 36.5 ± 8.3 35.3 ± 8.6
Country of birth, number (%)
Australia 429 (79.3) 383 (81.8) 25,977 (68.3)
United Kingdom 41 (7.6) 32 (6.8) 2,774 (7.3)
Italy 45 (8.3) 39 (8.3) 4,999 (13.2)
Greece 26 (4.8) 14 (3.0) 4,264 (11.2)
Education level, number (%)
Primary school 85 (15.8) 50 (10.7) 7,107 (18.8)
Some high school 255 (47.3) 192 (41.2) 14,422 (38.2)
Completed high school 112 (20.8) 102 (21.9) 7,814 (20.7)
Degree/diploma 87 (16.1) 122 (26.2) 8,426 (22.3)
Data reported as the mean ± standard deviation, except where indicated. MCCS, Melbourne Collaborative Cohort Study; JR, joint replacement.Arthritis Research & Therapy    Vol 11 No 2    Wang et al.
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Table 2
Relationship between adiposity measures and risk of primary joint replacement
Variable Number of cases in each quartile Hazard ratio 95% confidence interval P value
Weight (kg)
Q1 (F <59.7, M <73.0) 136 (9,756) 1.00
Q2 (F 59.7 to 66.2, M 73.0 to 79.7) 202 (9,485) 1.58 1.27 to 1.97
Q3 (F 66.2 to 74.6, M 79.7 to 87.4) 269 (9,418) 2.17 1.77 to 2.67
Q4 (F >74.6, M >87.4) 401 (9,329) 3.44 2.83 to 4.18
Linear model (per 10 kg) 1.42 1.36 to 1.48 <0.001
Body mass index (kg/m2)
Q1 (F <23.2, M <24.7) 128 (9,663) 1.00
Q2 (F 23.2 to 25.9, M 24.7 to 26.8) 211 (9,511) 1.65 1.32 to 2.05
Q3 (F 25.9 to 29.3, M 26.8 to 29.2) 302 (9,458) 2.48 2.01 to 3.05
Q4 (F >29.3, M >29.2) 367 (9,354) 3.44 2.80 to 4.22
Linear model (per 5 kg/m2) 1.60 1.51 to 1.70 <0.001
Waist circumference (cm)
Q1 (F <71.0, M <87.0) 136 (9,943) 1.00
Q2 (F 71.0 to 78.0, M 87.0 to 93.0) 222 (9,612) 1.59 1.29 to 1.97
Q3 (F 78.0 to 87.0, M 93.0 to 99.0) 290 (9,399) 2.07 1.68 to 2.54
Q4 (F >87.0, M >99.0) 360 (9,025) 2.77 2.26 to 3.39
Linear model (per 10 cm) 1.38 1.31 to 1.45 <0.001
Waist-to-hip ratio
Q1 (F < 0.74, M < 0.88) 193 (9,553) 1.00
Q2 (F 0.74 to 0.78, M 0.88 to 0.92) 234 (9,516) 1.13 0.94 to 1.37
Q3 (F 0.78 to 0.82, M 0.92 to 0.96) 264 (9,498) 1.23 1.02 to 1.48
Q4 (F > 0.82, M > 0.96) 317 (9,410) 1.46 1.21 to 1.76
Linear model (per 0.1 unit) 1.23 1.12 to 1.35 <0.001
Fat mass (kg)
Q1 (F <21.1, M <18.4) 125 (9,586) 1.00
Q2 (F 21.1 to 26.5, M 18.4 to 23.0) 209 (9,502) 1.71 1.37 to 2.13
Q3 (F 26.5 to 32.9, M 23.0 to 27.9) 273 (9,438) 2.26 1.83 to 2.80
Q4 (F >32.9, M >27.9) 398 (9,312) 3.51 2.87 to 4.30
Linear model (per 10 kg) 1.61 1.52 to 1.71 <0.001
Percentage fat (%)
Q1 (F <35.3, M <25.0) 143 (9,568) 1.00
Q2 (F 35.3 to 40.1, M 25.0 to 28.9) 205 (9,506) 1.45 1.17 to 1.80
Q3 (F 40.1 to 44.6, M 28.9 to 32.6) 260 (9,451) 1.86 1.51 to 2.28
Q4 (F >44.6, M >32.6) 397 (9,313) 2.99 2.46 to 3.63
Linear model (per 10%) 2.01 1.81 to 2.22 <0.001
All models using sex-specific quartiles of adiposity measures adjusted for age, gender, country of birth, and highest level of education. All models 
using continuous adiposity measures adjusted for age, country of birth, and highest level of education, stratifying by gender, representing an 
approximate change of one standard deviation for each of the adiposity measures. Q1, first quartile; Q2, second quartile; Q3, third quartile; Q4, 
fourth quartile; F, female; M, male.Available online http://arthritis-research.com/content/11/2/R31
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Table 3
Relationship between adiposity measures and risk of primary joint replacement by gender
Females Males
Variable Hazard ratio (95% confidence interval) P value Hazard ratio (95% confidence interval) P value
Weight, kg
Q1 (F <59.7, M <73.0) 1.00 1.00
Q2 (F 59.7 to 66.2, M 73.0 to 79.7) 1.84 (1.37 to 2.46) 1.30 (0.93 to 1.80)
Q3 (F 66.2 to 74.6, M 79.7 to 87.4) 2.69 (2.04 to 3.54) 1.58 (1.15 to 2.16)
Q4 (F >74.6, M >87.4) 4.12 (3.16 to 5.37) 2.60 (1.93, 3.49)
Linear model (per 10 kg) 1.42 (1.35 to 1.50) <0.001 1.41 (1.31 to 1.52) <0.001
Body mass index, kg/m2
Q1 (F <23.2, M <24.7) 1.00 1.00
Q2 (F 23.2 to 25.9, M 24.7 to 26.8) 1.85 (1.38 to 2.47) 1.40 (1.00 to 1.97)
Q3 (F 25.9 to 29.3, M 26.8 to 29.2) 2.68 (2.03 to 3.54) 2.23 (1.63 to 3.06)
Q4 (F >29.3, M >29.2) 3.87 (2.94 to 5.09) 2.85 (2.08 to 3.90)
Linear model (per 5 kg/m2) 1.55 (1.45 to 1.66) <0.001 1.76 (1.56 to 1.98) <0.001
Waist circumference, cm
Q1 (F <71.0, M <87.0) 1.00 1.00
Q2 (F 71.0 to 78.0, M 87.0 to 93.0) 1.72 (1.29 to 2.28) 1.45 (1.05 to 2.02)
Q3 (F 78.0 to 87.0, M 93.0 to 99.0) 2.24 (1.70 to, 2.94) 1.84 (1.33 to 2.53)
Q4 (F >87.0, M >99.0) 3.03 (2.31 to 3.97) 2.39 (1.76 to 3.24)
Linear model (per 10 cm) 1.36 (1.27 to 1.44) <0.001 1.41 (1.28 to 1.55) <0.001
Waist-to-hip ratio
Q1 (F <0.74, M <0.88) 1.00 1.00
Q2 (F 0.74 to 0.78, M 0.88 to 0.92) 1.25 (0.98 to 1.59) 0.94 (0.69 to 1.29)
Q3 (F 0.78 to 0.82, M 0.92 to 0.96) 1.25 (0.98 to 1.59) 1.16 (0.86 to 1.57)
Q4 (F > 0.82, M > 0.96) 1.32 (1.04 to 1.68) 1.62 (1.22 to 2.15)
Linear model (per 0.1 unit) 1.16 (1.03 to 1.30) 0.01 1.36 (1.16 to 1.60) <0.001
Fat mass, kg
Q1 (F <21.1, M <18.4) 1.00 1.00
Q2 (F 21.1 to 26.5, M 18.4 to 23.0) 1.85 (1.38 to 2.49) 1.53 (1.09 to 2.15)
Q3 (F 26.5 to 32.9, M 23.0 to 27.9) 2.60 (1.96 to, 3.45) 1.84 (1.33 to 2.55)
Q4 (F >32.9, M >27.9) 4.04 (3.09 to 5.29) 2.80 (2.06 to 3.81)
Linear model (per 10 kg) 1.58 (1.47 to 1.69) <0.001 1.69 (1.51 to 1.89) <0.001
Percentage fat, %
Q1 (F <35.3, M <25.0) 1.00 1.00
Q2 (F 35.3 to 40.1, M 25.0 to 28.9) 1.47 (1.11 to 1.96) 1.43 (1.04 to 1.99)
Q3 (F 40.1 to 44.6, M 28.9 to 32.6) 2.12 (1.62 to 2.77) 1.51 (1.09 to 2.08)
Q4 (F >44.6, M >32.6) 3.29 (2.55 to 4.24) 2.56 (1.90 to 3.45)
Linear model (per 10%) 1.99 (1.76 to 2.26) <0.001 2.00 (1.67 to 2.39) <0.001
All models adjusted for age, country of birth, and highest level of education. Linear models represent an approximate change of one standard 
deviation for each of the adiposity measures. Q1, first quartile; Q2, second quartile; Q3, third quartile; Q4, fourth quartile; F, female; M, male.Arthritis Research & Therapy    Vol 11 No 2    Wang et al.
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ated with the risk of knee replacement than hip replacement.
Indeed adipose tissue, which was once thought to be a pas-
sive store of energy, is now considered an endocrine organ,
releasing a multitude of factors, including cytokines such as
TNF and IL-6, as well as adipokines, such as leptin, adi-
ponectin and resistin [35]. Both TNF and IL-6 have been
implicated in cartilage destruction in OA [36,37], while leptin
is a key regulator of chondrocyte metabolism and plays an
important role in the pathophysiology of OA [38]. Such find-
ings demonstrate the potential role of metabolic factors
related to adiposity in the context of OA and, ultimately, of joint
replacement.
The WHR is a surrogate measure of central adiposity that
includes the visceral and abdominal subcutaneous depots.
Recent data have shown some biological differences between
intraabdominal visceral fat and peripheral subcutaneous fat
[39]. Visceral adipose tissue and its adipose-tissue resident
macrophages produce more proinflamatory cytokines, like
TNF and IL-6, and less adiponectin [39]. Leptin secretion is
greater from subcutaneous than from visceral fat tissue [40].
A limitation of the WHR is that it is not able to discern between
the metabolically and physically different types of fat. In addi-
tion, the WHR becomes even less reliable in people who have
both greater central and gynoid fat, and therefore may lead to
an underestimation of observed associations. This underesti-
mation may in part explain the lower sensitivity and weaker
association of WHR with joint replacement than the other adi-
posity measures.
We had virtually complete follow-up in this prospective study
as the identification of incident primary knee and hip replace-
ment was done by record linkage to the NJRR, which has com-
plete coverage of the cohort participants. While the
recruitment of MCCS participants and data collection com-
menced in 1990 to 1994, the NJRR started joint replacement
data collection in Victoria in 2001. We therefore do not have
complete and reliable joint replacement data for the study pop-
ulation prior to 2001. Although we excluded those MCCS par-
ticipants who reported a joint replacement prior to 1 January
2001 at the second follow-up, this information may be unrelia-
ble and is only known for 68% of the original cohort. As a
result, some misclassification of joint replacement status may
have occurred – although it is likely to have been nondifferen-
tial in relation to the adiposity measures, which may have
underestimated the strength of any observed associations.
The MCCS did not collect data on occupational activities such
as bending and lifting, and thus we were unable to adjust for
these factors in the analysis. Although total joint replacement
is used as a proxy for severe symptomatic OA, the utilization of
joint replacement in the treatment of OA may be influenced by
a number of factors such as access to healthcare, physician
bias, and patient-level factors, in addition to disease severity
[41]. We therefore adjusted for age, gender, country of birth,
and highest level of education in the analysis to counter this
issue.
A particular issue for bioelectric impedance analysis is the
absence of a standard equation to estimate the fat-free mass.
We chose a formula developed using subjects of similar eth-
nicity, age, and BMI distribution to the MCCS population [23]
that was validated using sound statistical techniques. There is
evidence that body hydration, a status difficult to assess in
large epidemiological studies, has a strong effect on the esti-
mation of FM based on bioelectric impedance analysis [42].
Any between-subject variability in hydration level in the current
study would therefore have resulted in greater attenuation of
the relationship between FM and the risk of primary joint
replacement. Another concern is that the measurement error
in the anthropometric variables would have underestimated
Table 4
Relationship between adiposity measures and risk of primary knee and hip replacement
Primary knee replacement (n = 541) Primary hip replacement (n = 468) Heterogeneity of hazard 
ratios
Hazard ratio (95% confidence 
interval)
P value Hazard ratio (95% confidence 
interval)
P value (P value)
Weight (per 10 kg) 1.58 (1.51 to 1.65) <0.001 1.22 (1.15 to 1.30) <0.001 <0.0001
Body mass index (per 5 kg/
m2)
1.88 (1.76 to 2.00) <0.001 1.26 (1.15 to 1.38) <0.001 <0.0001
Waist circumference (per 
10 cm)
1.62 (1.53 to 1.72) <0.001 1.10 (1.01 to 1.19) 0.03 <0.0001
Waist-to-hip ratio (per 0.1 
unit)
1.43 (1.29 to 1.58) <0.001 1.01 (0.85 to 1.19) 0.92 0.0004
Fat mass (per 10 kg) 1.88 (1.76 to 2.00) <0.001 1.29 (1.18 to 1.41) <0.001 <0.0001
Percentage fat (per 10%) 2.84 (2.47 to 3.26) <0.001 1.37 (1.19 to 1.57) <0.001 <0.0001
All models adjusted for age, country of birth, and highest level of education, stratifying by gender, representing an approximate change of one 
standard deviation for each of the adiposity measures.Available online http://arthritis-research.com/content/11/2/R31
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the associations observed in the study, and this effect would
be greatest for the bioelectric impedance analysis-based
measures.
Conclusion
In summary, the risk of primary knee replacement and hip joint
replacement for OA appears to be related to BMI, both adi-
pose mass and central adiposity, whereas the WHR was sig-
nificant for knee replacement but not hip replacement. This
suggests both biomechanical and metabolic mechanisms
associated with adiposity contribute to the risk of joint replace-
ment, with stronger evidence at the knee rather than at the hip.
The obesity epidemic occurring in developed countries is likely
to have a significant impact on the future demands for knee
and hip replacements for OA, and understanding the mecha-
nism of action will be important in effective prevention of OA.
Competing interests
The authors declare that they have no competing of interests.
Authors' contributions
YW participated in the design of the study, performed the sta-
tistical analysis and the interpretation of data, and drafted the
manuscript. JAS participated in the acquisition of data, helped
to perform the statistical analysis, and reviewed the manu-
script. AEW and AJT helped the interpretation of data, and
reviewed the manuscript. DRE, GGG, and SG participated in
the design of the study and the acquisition of data, and
reviewed the manuscript. FMC participated in the design of
the study, helped with the interpretation of data, and reviewed
the manuscript. All authors read and approved the final manu-
script.
Acknowledgements
The MCCS recruitment was funded by VicHealth and The Cancer 
Council of Victoria. The MCCS was funded by a program grant from the 
National Health and Medical Research Council (NHMRC 209057), a 
capacity-building grant (NHMRC 251533), and an enabling grant 
(NHMRC 396414), and was further supported by infrastructure pro-
vided by The Cancer Council of Victoria. YW and AEW are the recipi-
ents of NHMRC Public Health (Australia) Fellowships (NHMRC 
465142 and NHMRC 317840, respectively). The authors would espe-
cially like to thank data manager Lisa Ingerson and statistician Nicole 
Pratt from the Australian Orthopaedic Association National Joint 
Replacement Registry, and Ms Georgina Marr from The Cancer Council 
Victoria.
References
1. Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M: Prevalence
of primary and revision total hip and knee arthroplasty in the
United States from 1990 through 2002.  J Bone Joint Surg Am
2005, 87:1487-1497.
2. Australian Orthopaedic Association National Joint Replacement
Registry: Annual Report Adelaide: AOA; 2007. 
3. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jor-
dan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M,
McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G,
Sharma L, Buckwalter JA, Brandt KD, Fries JF: Osteoarthritis:
new insights. Part 1: the disease and its risk factors.  Ann Intern
Med 2000, 133:635-646.
4. Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF:
Obesity and knee osteoarthritis. The Framingham Study.  Ann
Intern Med 1988, 109:18-24.
5. Hart DJ, Spector TD: The relationship of obesity, fat distribution
and osteoarthritis in women in the general population: the
Chingford Study.  J Rheumatol 1993, 20:331-335.
6. Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ: Weight
loss reduces the risk for symptomatic knee osteoarthritis in
women. The Framingham Study.  Ann Intern Med 1992,
116:535-539.
7. Felson DT, Zhang Y: An update on the epidemiology of knee
and hip osteoarthritis with a view to prevention.  Arthritis
Rheum 1998, 41:1343-1355.
8. Cooper C, Inskip H, Croft P, Campbell L, Smith G, McLaren M,
Coggon D: Individual risk factors for hip osteoarthritis: obesity,
hip injury, and physical activity.  Am J Epidemiol 1998,
147:516-522.
9. Tepper S, Hochberg MC: Factors associated with hip osteoar-
thritis: data from the First National Health and Nutrition Exam-
ination Survey (NHANES-I).  Am J Epidemiol 1993,
137:1081-1088.
10. Sturmer T, Gunther KP, Brenner H: Obesity, overweight and pat-
terns of osteoarthritis: the Ulm Osteoarthritis Study.  J Clin
Epidemiol 2000, 53:307-313.
11. Lievense AM, Bierma-Zeinstra SM, Verhagen AP, van Baar ME,
Verhaar JA, Koes BW: Influence of obesity on the development
of osteoarthritis of the hip: a systematic review.  Rheumatology
(Oxford) 2002, 41:1155-1162.
12. Reijman M, Pols HA, Bergink AP, Hazes JM, Belo JN, Lievense AM,
Bierma-Zeinstra SM: Body mass index associated with onset
and progression of osteoarthritis of the knee but not of the
hip: the Rotterdam Study.  Ann Rheum Dis 2007, 66:158-162.
13. Wendelboe AM, Hegmann KT, Biggs JJ, Cox CM, Portmann AJ,
Gildea JH, Gren LH, Lyon JL: Relationships between body mass
indices and surgical replacements of knee and hip joints.  Am
J Prev Med 2003, 25:290-295.
14. Liu B, Balkwill A, Banks E, Cooper C, Green J, Beral V: Relation-
ship of height, weight and body mass index to the risk of hip
and knee replacements in middle-aged women.  Rheumatology
(Oxford) 2007, 46:861-867.
15. Flugsrud GB, Nordsletten L, Espehaug B, Havelin LI, Meyer HE:
Risk factors for total hip replacement due to primary osteoar-
thritis: a cohort study in 50,034 persons.  Arthritis Rheum 2002,
46:675-682.
16. Karlson EW, Mandl LA, Aweh GN, Sangha O, Liang MH, Grod-
stein F: Total hip replacement due to osteoarthritis: the impor-
tance of age, obesity, and other modifiable risk factors.  Am J
Med 2003, 114:93-98.
17. Flugsrud GB, Nordsletten L, Espehaug B, Havelin LI, Engeland A,
Meyer HE: The impact of body mass index on later total hip
arthroplasty for primary osteoarthritis: a cohort study in 1.2
million persons.  Arthritis Rheum 2006, 54:802-807.
18. Roubenoff R: Applications of bioelectrical impedance analysis
for body composition to epidemiologic studies.  Am J Clin Nutr
1996, 64:459S-462S.
19. Grinker JA, Tucker KL, Vokonas PS, Rush D: Changes in patterns
of fatness in adult men in relation to serum indices of cardio-
vascular risk: the Normative Aging Study.  Int J Obes Relat
Metab Disord 2000, 24:1369-1378.
20. Lohmander LS, Gerhardsson M, Rollof J, Nilsson PM, Engstrom G:
Incidence of severe knee and hip osteoarthritis in relation to
different measures of body mass. A population-based pro-
spective cohort study.  Ann Rheum Dis 2008 in press.
21. Giles GG, English DR: The Melbourne Collaborative Cohort
Study.  IARC Sci Publ 2002, 156:69-70.
22. Lohman TG, Roche AF, Martorell R, editors: Anthropometric
Standardization Reference Manual Champaign, IL: Kinetics
Books; 1988:90. 
23. Roubenoff R, Baumgartner RN, Harris TB, Dallal GE, Hannan MT,
Economos CD, Stauber PM, Wilson PW, Kiel DP: Application of
bioelectrical impedance analysis to elderly populations.  J Ger-
ontol A Biol Sci Med Sci 1997, 52:M129-M136.
24. Graves SE, Davidson D, Ingerson L, Ryan P, Griffith EC, McDer-
mott BF, McElroy HJ, Pratt NL: The Australian Orthopaedic
Association National Joint Replacement Registry.  Med J Aust
2004, 180:S31-S34.Arthritis Research & Therapy    Vol 11 No 2    Wang et al.
Page 10 of 10
(page number not for citation purposes)
25. Lean ME, Han TS, Morrison CE: Waist circumference as a meas-
ure for indicating need for weight management.  BMJ 1995,
311:158-161.
26. Lunn M, McNeil D: Applying Cox regression to competing risks.
Biometrics 1995, 51:524-532.
27. Katz BP, Freund DA, Heck DA, Dittus RS, Paul JE, Wright J, Coyte
P, Holleman E, Hawker G: Demographic variation in the rate of
knee replacement: a multi-year analysis.  Health Serv Res
1996, 31:125-140.
28. Merx H, Dreinhofer K, Schrader P, Sturmer T, Puhl W, Gunther KP,
Brenner H: International variation in hip replacement rates.
Ann Rheum Dis 2003, 62:222-226.
29. Hawker GA, Wright JG, Glazier RH, Coyte PC, Harvey B, Williams
JI, Badley EM: The effect of education and income on need and
willingness to undergo total joint arthroplasty.  Arthritis Rheum
2002, 46:3331-3339.
30. Sharma L, Lou C, Cahue S, Dunlop DD: The mechanism of the
effect of obesity in knee osteoarthritis: the mediating role of
malalignment.  Arthritis Rheum 2000, 43:568-575.
31. Abbate LM, Stevens J, Schwartz TA, Renner JB, Helmick CG, Jor-
dan JM: Anthropometric measures, body composition, body fat
distribution, and knee osteoarthritis in women.  Obesity (Silver
Spring) 2006, 14:1274-1281.
32. Hochberg MC, Lethbridge-Cejku M, Scott WW Jr, Reichle R, Plato
CC, Tobin JD: The association of body weight, body fatness
and body fat distribution with osteoarthritis of the knee: data
from the Baltimore Longitudinal Study of Aging.  J Rheumatol
1995, 22:488-493.
33. Davis MA, Neuhaus JM, Ettinger WH, Mueller WH: Body fat dis-
tribution and osteoarthritis.  Am J Epidemiol 1990,
132:701-707.
34. Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F: Metabolic syn-
drome: from global epidemiology to individualized medicine.
Clin Pharmacol Ther 2007, 82:509-524.
35. Pottie P, Presle N, Terlain B, Netter P, Mainard D, Berenbaum F:
Obesity and osteoarthritis: more complex than predicted!  Ann
Rheum Dis 2006, 65:1403-1405.
36. Evans CH: Novel biological approaches to the intra-articular
treatment of osteoarthritis.  BioDrugs 2005, 19:355-362.
37. Malemud CJ: Cytokines as therapeutic targets for osteoarthri-
tis.  BioDrugs 2004, 18:23-35.
38. Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P,
Pottie P: Evidence for a key role of leptin in osteoarthritis.
Arthritis Rheum 2003, 48:3118-3129.
39. Hamdy O, Porramatikul S, Al-Ozairi E: Metabolic obesity: the par-
adox between visceral and subcutaneous fat.  Curr Diabetes
Rev 2006, 2:367-373.
40. Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J,
Lonnqvist F, Arner P: Leptin secretion from subcutaneous and
visceral adipose tissue in women.  Diabetes 1998, 47:913-917.
41. Kane RL, Wilt T, Suarez-Almazor ME, Fu SS: Disparities in total
knee replacements: a review.  Arthritis Rheum 2007,
57:562-567.
42. Thompson DL, Thompson WR, Prestridge TJ, Bailey JG, Bean MH,
Brown SP, McDaniel JB: Effects of hydration and dehydration
on body composition analysis: a comparative study of bioelec-
tric impedance analysis and hydrodensitometry.  J Sports Med
Phys Fitness 1991, 31:565-570.